O'Byrne Jason
SEC CIK 1871145 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 2026-03-20 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | J - Other | $0.00 | -2,500 | 160.1K | -2% | $0 | |
| I | 2026-03-23 | 2026-03-20 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | J - Other | $0.00 | +2,500 | 2,500 | New | $0 |
| 2026-02-26 | 2026-02-24 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | S - Sale | $9.53 | -1,634 | 162.6K | -1.0% | -$15.6K | |
| D | 2026-02-24 | 2026-02-22 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +55.0K | 166.3K | +49% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | S - Sale | $7.45 | -2,089 | 164.2K | -1% | -$15.6K |
| 2025-11-18 | 2025-11-17 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | S - Sale | $5.56 | -6,799 | 110.7K | -6% | -$37.8K | |
| D | 2025-02-25 | 2025-02-22 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +40.0K | 115.0K | +53% | $0 |
| D | 2024-11-18 | 2024-11-15 | VIR | Vir Biotechnology, Inc. | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2024-02-22 | 2024-02-20 | CRBU | Caribou Biosciences, Inc. | O'Byrne Jason | CFO | A - Grant | $0.00 | +33.0K | 59.2K | +126% | $0 |
| D | 2022-02-08 | 2022-02-08 | CRBU | Caribou Biosciences, Inc. | O'Byrne Jason | CFO | M - OptEx | $4.11 | +24.3K | 24.3K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations